MoBiTec GmbH, Germany, Closes Distribution Agreement For Stem Cells, Primary Cells And Reagents With Cyagen Biosciences Inc., China, For The German Market

Online, July 30, 2012 (Newswire.com) - Cyagen produces the world's most comprehensive list of research-use stem cells. Offerings include embryonic stem cells and somatic stem cells from various species, along with their genetically modified derivatives.

In addition, Cyagen produces specialized cell culture media, differentiation media, cryopreservation media and an assortment of related reagents optimized for use with our cells. Also offered are contract research services for stem cell derivation, in vitro and in vivo characterization, gene expression, gene silencing, genetic modification and much more.

Highlights:
· World's Most Comprehensive Research-use Stem Cell Bank
· Stem Cells and Primary Cells for Drug Screen
· Leading Transgenic Mouse Services Provider
· Most Versatile DNA Vector Construction Services
· Free On-line Tool: vectorbuilder

Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteocytes, adipocytes, and chondrocytes. In addition, MSCs amplify quickly and are capable of generating a local immunosuppressive microenvironment, which contributes to their wide applications in tissue engineering, cell therapy and gene therapy.

Cyagen's OriCellTM Mesenchymal Stem Cells are derived from healthy human or qualified animals' bone marrow, cultured as a monolayer, and cryopreserved at the second passage. These cells express specific clusters of differentiation proteins for MSCs, and have a strong capacity for self-renewal while maintaining their multipotency. To ensure the highest quality to our customers, these cells have been tested negative for bacteria, fungi, and mycoplasma.

Joerg Ronnenberg, chief executive officer of MoBiTec GmbH, said: "This is an important step for the strategy to make a technology transfer of Cyagen's expertise and their products to a quality distributor in order to increase the representation on the market. This agreement with a well-known leader in stem cell technology will have a major impact on the sales of stem cell products in Germany and other European countries."

Cyagen is a life sciences company committed to bringing high-quality reagents and services to the life sciences community at favorable prices.